These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16454692)

  • 1. Tissue distribution and pharmacodynamics: a complicated relationship.
    Lin JH
    Curr Drug Metab; 2006 Jan; 7(1):39-65. PubMed ID: 16454692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).
    Besunder JB; Reed MD; Blumer JL
    Clin Pharmacokinet; 1988 Apr; 14(4):189-216. PubMed ID: 3292100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporters in absorption, distribution, and elimination.
    Scherrmann JM
    Chem Biodivers; 2009 Nov; 6(11):1933-42. PubMed ID: 19937831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Distribution to Human Tissues: Prediction and Examination of the Basic Assumption in In Vivo Pharmacokinetics-Pharmacodynamics (PK/PD) Research.
    Poulin P
    J Pharm Sci; 2015 Jun; 104(6):2110-2118. PubMed ID: 25808270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics.
    Fan J; de Lannoy IA
    Biochem Pharmacol; 2014 Jan; 87(1):93-120. PubMed ID: 24055064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics in the elderly.
    Crooks J; O'Malley K; Stevenson IH
    Clin Pharmacokinet; 1976; 1(4):280-96. PubMed ID: 797500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy.
    Obach RS
    Pharmacol Rev; 2013 Apr; 65(2):578-640. PubMed ID: 23406671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental Changes in Pharmacokinetics and Pharmacodynamics.
    van den Anker J; Reed MD; Allegaert K; Kearns GL
    J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S10-S25. PubMed ID: 30248190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring tissue drug levels by clinical microdialysis.
    Müller M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():57-9. PubMed ID: 19807204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport vs. Metabolism: What Determines the Pharmacokinetics and Pharmacodynamics of Drugs? Insights From the Extended Clearance Model.
    Patilea-Vrana G; Unadkat JD
    Clin Pharmacol Ther; 2016 Nov; 100(5):413-418. PubMed ID: 27448198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging siRNA Design Principles and Consequences for Biotransformation and Disposition in Drug Development.
    Humphreys SC; Thayer MB; Campbell J; Chen WLK; Adams D; Lade JM; Rock BM
    J Med Chem; 2020 Jun; 63(12):6407-6422. PubMed ID: 32352779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
    Masimirembwa CM; Bredberg U; Andersson TB
    Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors contributing to variability in drug pharmacokinetics. II. Drug distribution.
    Routledge PA
    J Clin Hosp Pharm; 1985 Mar; 10(1):15-23. PubMed ID: 3889062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug distribution. The forgotten relative in clinical pharmacokinetics.
    Eichler HG; Müller M
    Clin Pharmacokinet; 1998 Feb; 34(2):95-9. PubMed ID: 9515183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theory and Application of Microdialysis in Pharmacokinetic Studies.
    Zhuang L; Xia H; Gu Y; Derendorf H; Li Y; Liu C
    Curr Drug Metab; 2015; 16(10):919-31. PubMed ID: 26264199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.
    Dostalek M; Akhlaghi F; Puzanovova M
    Clin Pharmacokinet; 2012 Aug; 51(8):481-99. PubMed ID: 22668340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new concept.
    Reichel A
    Chem Biodivers; 2009 Nov; 6(11):2030-49. PubMed ID: 19937839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.
    Lai Y; Varma M; Feng B; Stephens JC; Kimoto E; El-Kattan A; Ichikawa K; Kikkawa H; Ono C; Suzuki A; Suzuki M; Yamamoto Y; Tremaine L
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):723-43. PubMed ID: 22509796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods to assess tissue-specific distribution and metabolism of drugs.
    Langer O; Müller M
    Curr Drug Metab; 2004 Dec; 5(6):463-81. PubMed ID: 15578942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.